Vanda Pharmaceuticals (VNDA) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Vanda Pharmaceuticals (VNDA) over the last 17 years, with Q4 2025 value amounting to $7.5 million.
- Vanda Pharmaceuticals' Other Gross PP&E Adjustments fell 711.37% to $7.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $7.5 million, marking a year-over-year decrease of 711.37%. This contributed to the annual value of $7.5 million for FY2025, which is 711.37% down from last year.
- Per Vanda Pharmaceuticals' latest filing, its Other Gross PP&E Adjustments stood at $7.5 million for Q4 2025, which was down 711.37% from -$6.8 million recorded in Q3 2025.
- In the past 5 years, Vanda Pharmaceuticals' Other Gross PP&E Adjustments ranged from a high of $8.1 million in Q4 2024 and a low of -$12.0 million during Q1 2024
- In the last 5 years, Vanda Pharmaceuticals' Other Gross PP&E Adjustments had a median value of -$8.7 million in 2022 and averaged -$5.6 million.
- In the last 5 years, Vanda Pharmaceuticals' Other Gross PP&E Adjustments skyrocketed by 8873.9% in 2021 and then plummeted by 2992.2% in 2024.
- Vanda Pharmaceuticals' Other Gross PP&E Adjustments (Quarter) stood at $3.2 million in 2021, then skyrocketed by 42.7% to $4.6 million in 2022, then skyrocketed by 33.17% to $6.1 million in 2023, then soared by 32.41% to $8.1 million in 2024, then dropped by 7.11% to $7.5 million in 2025.
- Its last three reported values are $7.5 million in Q4 2025, -$6.8 million for Q3 2025, and -$8.7 million during Q2 2025.